Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Interaction with mesenchymal stem cells provokes natural killer cells for enhanced IL-12/IL-18-induced interferon-gamma secretion.

Thomas H, Jäger M, Mauel K, Brandau S, Lask S, Flohé SB.

Mediators Inflamm. 2014;2014:143463. doi: 10.1155/2014/143463. Epub 2014 Apr 30.

PMID:
24876666
[PubMed - in process]
Free PMC Article
2.

Stimulation of mesenchymal stromal cells (MSCs) via TLR3 reveals a novel mechanism of autocrine priming.

Dumitru CA, Hemeda H, Jakob M, Lang S, Brandau S.

FASEB J. 2014 May 15. pii: fj.14-250159. [Epub ahead of print]

PMID:
24830384
[PubMed - as supplied by publisher]
3.

Bone marrow-derived mesenchymal stem cells migrate to healthy and damaged salivary glands following stem cell infusion.

Schwarz S, Huss R, Schulz-Siegmund M, Vogel B, Brandau S, Lang S, Rotter N.

Int J Oral Sci. 2014 May 9. doi: 10.1038/ijos.2014.23. [Epub ahead of print]

PMID:
24810808
[PubMed - as supplied by publisher]
4.

The role of tumour FoxP3 as prognostic marker in different subtypes of head and neck cancer.

Weller P, Bankfalvi A, Gu X, Dominas N, Lehnerdt GF, Zeidler R, Lang S, Brandau S, Dumitru CA.

Eur J Cancer. 2014 May;50(7):1291-300. doi: 10.1016/j.ejca.2014.02.016. Epub 2014 Mar 11.

PMID:
24630394
[PubMed - indexed for MEDLINE]
5.

Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy.

Pogorzelski M, Ting S, Gauler TC, Breitenbuecher F, Vossebein I, Hoffarth S, Markowetz J, Lang S, Bergmann C, Brandau S, Jawad JA, Schmid KW, Schuler M, Kasper S.

Cell Death Dis. 2014 Feb 27;5:e1091. doi: 10.1038/cddis.2014.62.

PMID:
24577089
[PubMed - in process]
Free PMC Article
6.

[Trying to unravel an unresolved issue in regenerative medicine: gene expression profiling of MSCs].

Jakob M, Bruderek K, Bootz F, Lang S, Brandau S.

Laryngorhinootologie. 2013 Jul;92(7):462-9. doi: 10.1055/s-0033-1337982. Epub 2013 Apr 16. German.

PMID:
23592442
[PubMed - indexed for MEDLINE]
7.

Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression.

Dumitru CA, Lang S, Brandau S.

Semin Cancer Biol. 2013 Jun;23(3):141-8. doi: 10.1016/j.semcancer.2013.02.005. Epub 2013 Feb 26. Review.

PMID:
23485549
[PubMed - indexed for MEDLINE]
8.

The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?

Brandau S, Moses K, Lang S.

Semin Cancer Biol. 2013 Jun;23(3):171-82. doi: 10.1016/j.semcancer.2013.02.007. Epub 2013 Feb 28. Review.

PMID:
23459190
[PubMed - indexed for MEDLINE]
9.

The dichotomy of neutrophil granulocytes in cancer.

Brandau S.

Semin Cancer Biol. 2013 Jun;23(3):139-40. doi: 10.1016/j.semcancer.2013.02.008. Epub 2013 Feb 27.

PMID:
23454237
[PubMed - indexed for MEDLINE]
10.

Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma.

Dumitru CA, Bankfalvi A, Gu X, Eberhardt WE, Zeidler R, Lang S, Brandau S.

Front Immunol. 2013 Feb 18;4:33. doi: 10.3389/fimmu.2013.00033. eCollection 2013.

PMID:
23423155
[PubMed]
Free PMC Article
11.

AHNAK and inflammatory markers predict poor survival in laryngeal carcinoma.

Dumitru CA, Bankfalvi A, Gu X, Zeidler R, Brandau S, Lang S.

PLoS One. 2013;8(2):e56420. doi: 10.1371/journal.pone.0056420. Epub 2013 Feb 7.

PMID:
23409183
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Cutting edge: An inactive chromatin configuration at the IL-10 locus in human neutrophils.

Tamassia N, Zimmermann M, Castellucci M, Ostuni R, Bruderek K, Schilling B, Brandau S, Bazzoni F, Natoli G, Cassatella MA.

J Immunol. 2013 Mar 1;190(5):1921-5. doi: 10.4049/jimmunol.1203022. Epub 2013 Jan 25.

PMID:
23355741
[PubMed - indexed for MEDLINE]
Free Article
13.

[Immunotherapy of head and neck cancer. Current developments].

Schuler PJ, Hoffmann TK, Gauler TC, Bergmann C, Brandau S, Lang S.

HNO. 2013 Jul;61(7):559-72. doi: 10.1007/s00106-012-2635-6. German.

PMID:
23247754
[PubMed - indexed for MEDLINE]
14.

Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer.

Trellakis S, Bruderek K, Hütte J, Elian M, Hoffmann TK, Lang S, Brandau S.

Innate Immun. 2013 Jun;19(3):328-36. doi: 10.1177/1753425912463618. Epub 2012 Nov 16.

PMID:
23160385
[PubMed - indexed for MEDLINE]
15.

Comparative functional cell biological analysis of mesenchymal stem cells of the head and neck region: potential impact on wound healing, trauma, and infection.

Jakob M, Hemeda H, Bruderek K, H Gerstner AO, Bootz F, Lang S, Brandau S.

Head Neck. 2013 Nov;35(11):1621-9. doi: 10.1002/hed.23196. Epub 2012 Nov 14.

PMID:
23152157
[PubMed - in process]
16.

Anti-Epidermal Growth Factor Receptor (EGFR) Antibodies Overcome Resistance of Ovarian Cancer Cells to Targeted Therapy and Natural Cytotoxicity.

Gottschalk N, Kimmig R, Lang S, Singh M, Brandau S.

Int J Mol Sci. 2012;13(9):12000-16. doi: 10.3390/ijms130912000. Epub 2012 Sep 20.

PMID:
23109896
[PubMed]
Free PMC Article
17.

Monocytes and the 38kDa-antigen of mycobacterium tuberculosis modulate natural killer cell activity and their cytolysis directed against ovarian cancer cell lines.

Gottschalk N, Lang S, Kimmig R, Singh M, Brandau S.

BMC Cancer. 2012 Oct 4;12:451. doi: 10.1186/1471-2407-12-451.

PMID:
23036052
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Protumor and antitumor functions of neutrophil granulocytes.

Brandau S, Dumitru CA, Lang S.

Semin Immunopathol. 2013 Mar;35(2):163-76. doi: 10.1007/s00281-012-0344-6. Epub 2012 Sep 25. Review.

PMID:
23007469
[PubMed - indexed for MEDLINE]
19.

Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells.

Akhmetzyanova I, Zelinskyy G, Schimmer S, Brandau S, Altenhoff P, Sparwasser T, Dittmer U.

Cancer Immunol Immunother. 2013 Feb;62(2):257-71. doi: 10.1007/s00262-012-1329-y. Epub 2012 Aug 14.

PMID:
22890822
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Oncogenic RAS simultaneously protects against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR signaling blockade.

Kasper S, Breitenbuecher F, Reis H, Brandau S, Worm K, Köhler J, Paul A, Trarbach T, Schmid KW, Schuler M.

Oncogene. 2013 Jun 6;32(23):2873-81. doi: 10.1038/onc.2012.302. Epub 2012 Jul 16.

PMID:
22797062
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk